Back to search

Article

Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological Assays

2020-09-24

Abstract excerpt

<h4>ABSTRACT</h4> The clinical and epidemiological use of SARS-CoV-2 antibody assays is under debate with urgent need to validate and verify the performance of SARS-CoV-2 serologic assays. We aim to assess the clinical and analytical performance of three commercial serological assays of SARS-CoV-2, comparing three anti-SARS-CoV-2-IgG ELISA and identifying the seroconversion and seroprevalence in our population. A...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b15d759-7243-535e-b0ed-2de46e953b67
DOI
10.1101/2020.09.22.20197046
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological AssaysDOI 10.1101/2020.09.22.20197046
Select a neighboring publication to make it the new centre.